APA (7th ed.) Citation

Bao, G., Wang, Z., Liu, L., Zhang, B., Song, S., Wang, D., . . . Zhu, X. (2024). Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer. European Journal of Nuclear Medicine & Molecular Imaging, 51(9), 2744. https://doi.org/10.1007/s00259-024-06704-y

Chicago Style (17th ed.) Citation

Bao, Guangfa, et al. "Targeting CXCR4/CXCL12 Axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 Antagonist in Triple-negative Breast Cancer." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 9 (2024): 2744. https://doi.org/10.1007/s00259-024-06704-y.

MLA (9th ed.) Citation

Bao, Guangfa, et al. "Targeting CXCR4/CXCL12 Axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 Antagonist in Triple-negative Breast Cancer." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 9, 2024, p. 2744, https://doi.org/10.1007/s00259-024-06704-y.